We investigated whether the inactivation of factor IXa contributes to the partial inhibition of thrombin formation that is observed at therapeutic concentrations of heparin. The action of standard unfractionated heparin (0.05 U/ml) on thrombin formation in the intrinsic system was compared to that of a mixture of dermatan sulfate (DS) and a synthetic pentasaccharide (PS). DS enhances the action of heparin cofactor II which inhibits thrombin only. PS specifically enhances the anti-factor Xa activity of antithrombin III (AI III). The concentrations of DS and PS were chosen so as to obtain equal anti-thrombin and anti-factor Xa activities as in 0.05 U/ml heparin. An extra inhibitory effect of heparin over the mixture is observed in situations where free factor IXa, not bound to factor VIIIa and phospholipid, limits the rate of thrombin formation, notably in contact activated plasma. We conclude that the inactivation of free factor IXa by heparin contributes importantly to the inhibition of thrombin formation in the intrinsic system such as e. g. measured in the activated partial thromboplastin time.
Summary
We investigated whether the inactivation of factor IXa contributes to the partial inhibition of thrombin formation that is observed at therapeutic concentrations of heparin. The action of standard unfractionated heparin (0.05 U/ml) on thrombin formation in the intrinsic system was compared to that of a mixture of dermatan sulfate (DS) and a synthetic pentasaccharide (PS). DS enhances the action of heparin cofactor II which inhibits thrombin only. PS specifically enhances the anti-factor Xa activity of antithrombin III (AI III). The concentrations of DS and PS were chosen so as to obtain equal anti-thrombin and anti-factor Xa activities as in 0.05 U/ml heparin. An extra inhibitory effect of heparin over the mixture is observed in situations where free factor IXa, not bound to factor VIIIa and phospholipid, limits the rate of thrombin formation, notably in contact activated plasma. We conclude that the inactivation of free factor IXa by heparin contributes importantly to the inhibition of thrombin formation in the intrinsic system such as e. g. measured in the activated partial thromboplastin time.
lntroduction
Heparin is known to catalyse the inactivation of the free serine proteases of blood coagulation by AT III (7, 2) .
-lhe amount of free thrombin that develops in clotting plasma is greatly reduced in the presence of heparin. This phenomenon can be either due to increased inactivation of the thrombin formed or to inhibition of prothrombin activation. This latter inhibition may be due to enhanced inactivation of activated factor X (factor Xa) or to inhibition of factors upstream in the coagulation cascade. Factor Xa inactivation has been assumed to be particularly important with low molecular weight heparins because they inactivate isolated factor Xa more readily than thrombtn (2) . We have found that in a thromboplastin activated system unfractionated heparin and most low molecular weight heparins exert their effect almost exclusively via inhibition of thrombin (3, 4) . A synthetic pentasaccharide (PS) identical to the main AT III binding site of heparin (5) and other very low molecular weight heparins do not or hardly affect thrombin breakdown but act via the inactivation of prothrombinase (3). In the intrinsic (contact activated-)system, all heparins postpone and inhibit prothrombin conversion. McNeely and Griffith (6) found that complete inhibition of thrombin generation by 0.5 U/ml heparin is not due to inhibition of the contact system. The question that we ask here is whether factor IXa inactivation is (co-)responsible for the partial inhibition seen at partially inhibiting heparin concentrations such as they occur in patients. Whether heparin in the intrinsic system acts also via enhanced inactivation of factor IXa is important for the interpretation of the effect of heparin on the activated partial thromboplastin time, the common test for estimating the effect of heparin administration in patients. We found earlier that the increase of the lag phase of thrombin formation in the intrinsic system is due to the inhibition of thrombin-mediated factor VIII activation and we surmised that the inhibition of prothrombin conversion could be due to the action of heparin-antithrombin III on factor IXa under these conditions (4). Our conclusions were based on calculation of prothrombin conversion rates from thrombin generation curves (7). Ofosu and his group came to similar conclusions by measuring prothrombin conversion by immunological methods (8, 9) .
In the present study we compare the action of heparin to that of a mixture of PS and DS that has the same anti-thrombin and anti-factor Xa activity as the heparin. DS, that acts via heparin cofactor II, inhibits thrombin only (10) , and the inhibitory action of PS is almost exclusively confined to factor Xa (11) . A mixture of PS and DS therefore can mimick the action of heparin with the exclusion of its effect on factor IXa. A larger effect of heparin compared to the DS-PS mixture thus can be used to spot the situations where factor IXa limits the rate of thrombin formation.
Methods
Heparin (4th international standard, f94 Ulmg), PS (batch IC 83.7423 at 800 International anti-factor Xa U/mg) and DS (batch IC 87.374) were gifts of Dr. Jean Choay (Centre Choay, Gentilly, France). The plasma used was pooled platelet poor citrated plasma from 20 healthy donors, stored in 1 ml portions at -80" C. It was defibrinated with reptilase before use Isolated clotting factors were obtained according to the following references: factor IXa: 12; factor VIII: 13; thrombin: 14; human brain thromboplastin: 15; phospholipid (80% phosphatidyl choline, 20o/o phosphatidyl serine) 16. S2238 (HD-phe-pip-arg-p-nitrophenyl acetate, 2 HCI) was obtained from KabiMtrum. Stockholm. Sweden.
The anti-factor Xa activities of PS and standard heparin dissolved in normal plasma were determined according to refs. 17 and 18.
Thrombin generation was assessed by spectrophotometdc determination of the amidolytic activity on 52238 that develops in plasma after triggering thrombin formation. The 400 pl reaction mixture contained 250 pl of plasma and 85 pl of buffer A (Tiis-HCl 50 mM, pH 7.35, 0.1 M NaCl, 0.5% egg albumin) with the heparin or other inhibitors so as to obtain the final concentrations indicated and 65 pl of the triggering solution.
The triggering solution consisted of 100 mM CaCl2 in buffer A with a) for the extrinsic pathway: human brain thromboplastin diluted so as to make the uninhibited, undefibrinated reaction mixture coagulate in 78-82 s, b) for the intrinsic pathway: 15 pg/ml of kaolin plus 7.2 pM of phospholipid, c) complete intrinsic factor X activator or d) incomplete intrinsic factor X activator. The complete factor X activating enzyme complex ("complete tenase"), consisted of factor IXa (7.2 nM), factor VIIIa (10 U/ml, i. e. 10 U/ml of factor VIII with 2.5 nM thrombin added 2 min before use) and 7.2 pM phospholipid. The incomplete factor X activator ("incomplete tenase") contained no factor VIIa but was otherwise identical Factors added in the course of the experiment were dissolved in 10 pl of buffer A so as to obtain the final concentration indicated.
The amidolytic activity generated in the plasma mixtures was determined in 10 pl aliquots that were transferred to 490 ml buffer A, at pH7.9, containing 0 2 mM 52238 and 20 mM EDTA. After 2 mrn,52238 conversion was stopped by adding 300 pl of concentrated acetic acid and the absorbancy at 405 nm was determined For details on the method see ref.
7. Fqq.3 Thrombin generation in plasma after triggering with complete tenase. Tiigger: factor lxa (1.2 nM), factor^Vllla (1.6 U/ml), phospholipid (1.2 pM) (final concentrations) and Ca'* (see methods). Symbols as in Fig. 1 100 TIME ( min ) Fig.4 Thrombin generation in plasma after triggering with incomplete tenase. Tiigger: factor IXa, phospholipid and Ca'*. Final concentrations as in Fig.3 , symbols as in Fig. 1 calculation of free thrombin concentrations is not dependent upon any assumption except that of a pseudo-first order reaction of thrombin with o.2-macroglobulin with the given rate constant This is verified by the observation that the calculated thrombin concentrations eventually descend to the zero level.
Results
We used a heparin concentration of 0.05 Ulml (0.26 pg/ml); this inhibits thromboplastin-induced thrombin formation about 50%, mainly through increasing thrombin breakdown (a). In order to mimick the anti-factor X a effect of the heparin we added PS to obtain the same anti-factor Xa activity as was present in the heparin solution, i.e. 0.05 anti-factor Xa-units/l (0.06 pg/ml). This has no anti-factor IXa action (11) . From experiments on plasmas deficient in factor IX we found previously that factor IX activation contributes only negligibly to thromboplastin-induced thrombin formation under our experimental conditions (20) . The inhibition caused by 0.05 U/ml of heparin, that is not caused by the PS added must therefore be due to thrombin inactivation. So we sought the concentration of DS that, in the presence of this amount of PS, would give 50% inhibition of the thrombin peak in the extrinsic system. This was 1.25 pglml (Fig. 1) . In this way the ,o_o Fig. 1 At any time l, the amidolytic activity (,4r) represents the activity of thrombin (!) and the cr2-macroglobulin-thrombin complex (!,). This latter complex builds up during the reaction and causes final levels of amidolytic activity equivalent to about 50 nM thrombin in the control and proportionally lower when heparin or DS favour the action of AT III or HC II. Because thrombin carries the physiologically important activities we prefer to give the time course of thrombin rather than that of amidolytic activity and therefore we subtracted C, from ,4, in order to obtain ?,. Under our conditions, the o2-macroglobulin-thrombin complex has a molar activity on 52238 of 0 55 times that of thrombin (7) . The concentration of the complex is obtained from an exact solution (see ref 19) of the differential equations that govern the generation of thrombin e.
-F 100 0 5 10 TIME ( min ) Fig.5 Thrombin generation in plasma after triggering with incomplete teiase. Effect of addition of factor VIIIa (1'6 U/m1) at t : 2' Symbols as in Fig.1 . See text for experimental details Flg.6 Thrombin generation in plasma after triggering with incomplete teiase. Effect of addition of factor VIIIa (1'6 U/ml) at t : 2 and factor IXa (1.2 nM) at t : 3. Symbols as in Fig l' See text tor experimental details PS-DS mixture is limited to inactivation of thrombin by DS and factor Xa by PS. We choose the concentrations of PS and DS so as to make these effects equal to respectively the anti-factor Xa and the anti-thrombin effect of 0.05 U/ml of heparin ' An extra effect of heparin over the PS-DS mixture is seen in contact activated plasmi and also when thrombin formation is started with factor IX a in the absence of factor VIII a (Figs ' 2 and induced disappearance of factor IXa. The presence of factor VIIIa (Fig.3) prevents the extra inhibition, so heparin must inhibit irei faCtor IXa, not bound to factor VIIIa and phospholipid. Thrombin formation triggered without added factor VIII; is not immediate as with complete tenase but shows a lag phase. Both in the presence and in the absence of inhibitors, the iag phase ends abruptly upon addition of factor VIIIa (Fig' 5) ' str-owing that factor VIII activation is compulsory' When factor VIIIa ii added after zeto time, the resulting thrombin formation is much smaller when heparin is present in the medium than with the PS-DS mixture. This indicates that during the absence of factor MIIa heparin specifically causes inactivation of a rate limiting reactani. Factor IXa is the obvious candidate' Indeed when fictor IXa is added after factor VIIIa an equally high burst of thrombin formation is seen with the two inhibitors (Fig' 6) ' It seems that thrombin generation is switched on by the apPearance of a threshold concentration of factor VIIIa but that the peak height is determined by the amount of factor IXa available at the moment that factor VIIIa appears. The effect of heparin on thrombin causes retardation of factor VIII activation and so prolongs the lag time. During the lag time heparin-Al III acts on itt" t ""
factor IXa that is available. The concentration of factor IXa that is left at the moment of switch on, then inhibition of thrombin generation, when triggered extrinsically, was equal for the DS-PS mixture and for 0.05 U/ml of heparin'
From Fig.2 it is seen that the PS-DS mixture inhibits intrinsically triggeied thrombin formation again for about 50%, but that treparin in this case inhibits significantly more (about 75%)' This difference must be caused by inhibition at or above the level of the intrinsic factor X activator. When the complete factor X activating complex is used as a starter (Fig.3 ) the difference between heparin and the PS/DS mixture disappears' It reappears when the reaction is started with alone factor IXa and phospholipid without factor VIIIa (Fig. a) . This strongly suggests that itt" i"tio.t of heparin on free factor IXa contributes to the lowering of the thrombin level in intrinsic coagulation' From "o-pa.itott of Figs. 2, 3 and 4 it is seen that when activated factor VIII is absent from the triggering mixture a lag time appears in the control experiment' Both the PS-DS mixture and heparin prolong the lag time but heparin is more effective than PS-DS is. When factor VIIIa is added during the lag time' thrombin generation starts immediately' independent of the inhibitor present (Fig.s) . The amount of thrombin formed is, however, much higher with PS-DS than with heparin' It appears that the addition of factor vIII a switches on thrombin formation but that the actual amount ofthrombin formed is dependent upon the concentration of a reactant that is specifically affected by heparin and not by PS-DS, i. e. factor IXa' That factor IX4 is rate timiting under these circumstances is seen in the experiments pr"r"tti"d in Fig.6 where the addition of factor IXa after iactor VIIIa causes an increase of thrombin formation that is essentially equal in the presence of heparin and in the presence of the DS-PS mixture. (Note that the difference in peak height in Fis.6 reflects the difference already existing at the moment of faitor IXa addition.) Discussion It has been demonstrated that heparin, at a concentration of 0.5 U/ml completely inhibits factor X activation because no factor X is aciivated under these circumstances (6)' We have investigated whether factor IXa inactivation contributes to the partial inhibition of thrombin generation seen at lower heparin ioncentrations. Indctivation of thrombin' factor Xa and/or factor IXa may contribute to this effect. The inhibitory effect of the 308 TIME ( min ) essentially different praperties of this type of drug. If the ratio of the different activities remains (approximately) constant, like in batches of unfiactionated heparin, each of the three tests will indicate the same level of active material in a plasma sample. However, then the ratios of the activities vary, such as in the case of lorv molecular weight heparins, the results of the different tests may no longer be compared.
